Table: Taiko Pharmaceutical -2017/18 parent results

Taiko Pharmaceutical

11/05/2018 07:01

May 11 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             8.97            7.82                                 
                 (+14.8 pct)     (+2.4 pct)                              
  Operating         1.77            1.36                                 
                 (+30.4 pct)     (+25.3 pct)                             
  Recurring         1.51            1.22                                 
                 (+24.4 pct)     (-28.2 pct)                             
  Net               1.05           878 mln                               
                 (+19.5 pct)     (-32.1 pct)                             
  EPS             74.15 yen       63.98 yen                              
  EPS Diluted     73.84 yen       63.44 yen                              
  Ann Div         25.00 yen       20.00 yen      25.00 yen               
  -Q2 Div            NIL             NIL         10.00 yen               
  -Q4 Div         25.00 yen       20.00 yen      15.00 yen               
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T